These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36916262)

  • 41. Kawasaki disease: an evolving paradigm.
    Greco A; De Virgilio A; Rizzo MI; Tombolini M; Gallo A; Fusconi M; Ruoppolo G; Pagliuca G; Martellucci S; de Vincentiis M
    Autoimmun Rev; 2015 Aug; 14(8):703-9. PubMed ID: 25882057
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Kawasaki Disease: Issues in Diagnosis and Treatment--A Developing Country Perspective.
    Singh S; Sharma A; Jiao F
    Indian J Pediatr; 2016 Feb; 83(2):140-5. PubMed ID: 26400032
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Kawasaki disease in children and adolescents].
    Neudorf U
    Z Rheumatol; 2011 Dec; 70(10):838-43. PubMed ID: 22139203
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kawasaki disease.
    Newburger JW; Fulton DR
    Curr Opin Pediatr; 2004 Oct; 16(5):508-14. PubMed ID: 15367843
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A report of two cases of Kawasaki disease treated with plasma exchange.
    Harada T; Ito S; Shiga K; Inaba A; Machida H; Aihara Y; Yokota S
    Ther Apher Dial; 2008 Apr; 12(2):176-9. PubMed ID: 18387169
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease.
    Yellen ES; Gauvreau K; Takahashi M; Burns JC; Shulman S; Baker AL; Innocentini N; Zambetti C; Pancheri JM; Ostrow A; Frazer JR; Sundel RP; Fulton DR; Newburger JW
    Pediatrics; 2010 Feb; 125(2):e234-41. PubMed ID: 20100771
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnosis and classification of Kawasaki disease.
    Sánchez-Manubens J; Bou R; Anton J
    J Autoimmun; 2014; 48-49():113-7. PubMed ID: 24485156
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kawasaki disease: part II. Complications and treatment.
    Bayers S; Shulman ST; Paller AS
    J Am Acad Dermatol; 2013 Oct; 69(4):513.e1-8; quiz 521-2. PubMed ID: 24034380
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Kawasaki disease in Iceland 1996-2005, epidemiology and complications].
    Olafsdottir HS; Oskarsson G; Haraldsson Á
    Laeknabladid; 2012 Feb; 98(2):91-5. PubMed ID: 22314510
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-coronary cardiac events, younger age, and IVIG unresponsiveness increase the risk for coronary aneurysms in Italian children with Kawasaki disease.
    Fabi M; Andreozzi L; Frabboni I; Dormi A; Corinaldesi E; Lami F; Cicero C; Tchana B; Francavilla R; Sprocati M; Bigucci B; Balsamo C; Valin PS; Di Fazzio G; Iughetti L; Valletta E; Marchetti F; Donti A; Lanari M
    Clin Rheumatol; 2021 Apr; 40(4):1507-1514. PubMed ID: 32936425
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An update on Kawasaki disease.
    Cimaz R; Falcini F
    Autoimmun Rev; 2003 Sep; 2(5):258-63. PubMed ID: 12965176
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neutropenia after intravenous immunoglobulin therapy is associated with coronary artery lesions in children with Kawasaki disease: a case control study.
    Wang Z; Weng F; Li C; Shi H; Tang Z; Qiu H; He Y; Wu R; Chu M
    BMC Pediatr; 2018 Feb; 18(1):76. PubMed ID: 29466965
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of Risk of Recrudescent Fever in Children With Kawasaki Disease Treated With Intravenous Immunoglobulin and Low-Dose vs High-Dose Aspirin.
    Platt B; Belarski E; Manaloor J; Ofner S; Carroll AE; John CC; Wood JB
    JAMA Netw Open; 2020 Jan; 3(1):e1918565. PubMed ID: 31899532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatic predominant presentation of Kawasaki disease in adolescence case report and review of literature.
    Pratap K; Gardner LS; Gillis D; Newman M; Wainwright D; Prentice R
    BMC Gastroenterol; 2020 Oct; 20(1):352. PubMed ID: 33109118
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kawasaki Disease: Beyond IVIG and Aspirin.
    Moussa T; Wagner-Weiner L
    Pediatr Ann; 2019 Oct; 48(10):e400-e405. PubMed ID: 31609999
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Septated pericarditis associated with Kawasaki disease: a brief case report.
    Sonçaği A; Devrim I; Karagöz T; Dilber E; Celiker A; Ozen S; Seçmeer G
    Turk J Pediatr; 2007; 49(3):312-4. PubMed ID: 17990588
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Kawasaki disease: diagnosis, management, and long-term implications.
    Satou GM; Giamelli J; Gewitz MH
    Cardiol Rev; 2007; 15(4):163-9. PubMed ID: 17575479
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epidemiology of Kawasaki Disease in children in Switzerland: a national prospective cohort study.
    Gradoux E; Di Bernardo S; Bressieux-Degueldre S; Mivelaz Y; Boulos Ksontini T; Prsa M; Sekarski N
    Swiss Med Wkly; 2022 May; 152():w30171. PubMed ID: 35748748
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peripheral follicular cytotoxic T -like cells in Kawasaki disease with coronary artery aneurysms: A case report.
    Xu M; Liu J; Pan L; Yang S
    Medicine (Baltimore); 2020 Dec; 99(52):e23714. PubMed ID: 33350751
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Kawasaki disease complicated with mild encephalitis/encephalopathy with a reversible splenial lesion: A case report and literature review].
    DU YY; Wang J; He L; Ji LN; Xu XW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):756-761. PubMed ID: 35950404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.